Microbiological Spectrum and Antimicrobial Susceptibility Patterns of Culture‐Positive Thoracic and Respiratory Specimens in Syria: A Retrospective Laboratory‐Based Study
Mohammad Alaa Aldakak, Alaa Senjab, Hussein Aljbawi, Ibrahim Alkhatib, Adnan Alkhatib, Bassam Darwish · 2026
Read Microbiological Spectrum and Antimicrobial Susceptibility Patterns of Culture‐Positive Thoracic and Respiratory Specimens in Syria: A Retrospective Laboratory‐Based Study by Mohammad Alaa Aldakak, Alaa Senjab, Hussein Aljbawi, Ibrahim Alkhatib, Adnan Alkhatib, Bassam Darwish (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13633434.txt.
Description
Mohammad Alaa Aldakak and co-authors survey microbes in chest and airway samples in Syria, and which drugs work on them. Their 2026 study uses 2022 to 2025 records from a private referral lab in Damascus. Of 356 eligible records, 136 had positive cultures, a rate of thirty eight point two percent. Samples were classed as chest space, deep lung or surgical, or airway. The first two groups formed the main analysis.
Bacteria made up ninety three point four percent of the positive finds. The top species was Staphylococcus aureus, at twenty nine point nine percent of bacterial isolates. Escherichia coli followed at twenty three point six percent, Klebsiella pneumoniae at twenty point five, and Pseudomonas aeruginosa at fourteen point two. Patients averaged 42 years old, and two thirds were male. Drug response was read against a standard guideline. The authors frame this as support for local resistance surveillance.
Catalog record
| CREATOR | Mohammad Alaa Aldakak, Alaa Senjab, Hussein Aljbawi, Ibrahim Alkhatib, Adnan Alkhatib, Bassam Darwish |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |